150 related articles for article (PubMed ID: 10699892)
1. Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay.
Bilchik A; Miyashiro M; Kelley M; Kuo C; Fujiwara Y; Nakamori S; Monden M; Hoon DS
Cancer; 2000 Mar; 88(5):1037-44. PubMed ID: 10699892
[TBL] [Abstract][Full Text] [Related]
2. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
3. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction.
Hoon DS; Sarantou T; Doi F; Chi DD; Kuo C; Conrad AJ; Schmid P; Turner R; Guiliano A
Int J Cancer; 1996 Oct; 69(5):369-74. PubMed ID: 8900369
[TBL] [Abstract][Full Text] [Related]
4. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.
Bilchik AJ; Saha S; Wiese D; Stonecypher JA; Wood TF; Sostrin S; Turner RR; Wang HJ; Morton DL; Hoon DS
J Clin Oncol; 2001 Feb; 19(4):1128-36. PubMed ID: 11181678
[TBL] [Abstract][Full Text] [Related]
5. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR.
Bostick PJ; Huynh KT; Sarantou T; Turner RR; Qi K; Giuliano AE; Hoon DS
Int J Cancer; 1998 Dec; 79(6):645-51. PubMed ID: 9842976
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.
Hoon DS; Kuo CT; Wen S; Wang H; Metelitsa L; Reynolds CP; Seeger RC
Am J Pathol; 2001 Aug; 159(2):493-500. PubMed ID: 11485908
[TBL] [Abstract][Full Text] [Related]
7. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients.
Koyanagi K; Kuo C; Nakagawa T; Mori T; Ueno H; Lorico AR; Wang HJ; Hseuh E; O'Day SJ; Hoon DS
Clin Chem; 2005 Jun; 51(6):981-8. PubMed ID: 15817820
[TBL] [Abstract][Full Text] [Related]
8. Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.
Kuo CT; Bostick PJ; Irie RF; Morton DL; Conrad AJ; Hoon DS
Clin Cancer Res; 1998 Feb; 4(2):411-8. PubMed ID: 9516930
[TBL] [Abstract][Full Text] [Related]
9. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
[TBL] [Abstract][Full Text] [Related]
10. Detection of beta-human chorionic gonadotropin mRNA as a marker for cutaneous malignant melanoma.
Doi F; Chi DD; Charuworn BB; Conrad AJ; Russell J; Morton DL; Hoon DS
Int J Cancer; 1996 Feb; 65(4):454-9. PubMed ID: 8621227
[TBL] [Abstract][Full Text] [Related]
11. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
[TBL] [Abstract][Full Text] [Related]
12. The use of molecular profiling of early colorectal cancer to predict micrometastases.
Bilchik AJ; Nora DT; Saha S; Turner R; Wiese D; Kuo C; Ye X; Morton DL; Hoon DS
Arch Surg; 2002 Dec; 137(12):1377-83. PubMed ID: 12470104
[TBL] [Abstract][Full Text] [Related]
13. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
16. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.
Hoon DS; Wang Y; Dale PS; Conrad AJ; Schmid P; Garrison D; Kuo C; Foshag LJ; Nizze AJ; Morton DL
J Clin Oncol; 1995 Aug; 13(8):2109-16. PubMed ID: 7636555
[TBL] [Abstract][Full Text] [Related]
17. Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients.
Rapanotti MC; Bianchi L; Ricozzi I; Campione E; Pierantozzi A; Orlandi A; Chimenti S; Federici G; Bernardini S
Br J Dermatol; 2009 Feb; 160(2):338-44. PubMed ID: 19067715
[TBL] [Abstract][Full Text] [Related]
18. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
19. Beta-human chorionic gonadotropin in semen: a marker for early detection of prostate cancer?
Daja MM; Aghmesheh M; Ow KT; Rohde PR; Barrow KD; Russell PJ
Mol Urol; 2000; 4(4):421-7. PubMed ID: 11156711
[TBL] [Abstract][Full Text] [Related]
20. Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
Koyanagi K; O'Day SJ; Gonzalez R; Lewis K; Robinson WA; Amatruda TT; Wang HJ; Elashoff RM; Takeuchi H; Umetani N; Hoon DS
J Clin Oncol; 2005 Nov; 23(31):8057-64. PubMed ID: 16258104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
